Thomas Dubin Insider Profile

4 Followers
Thomas Dubin, SVP & CLO at Alexion Pharmaceuticals, holds 40.25K shares in Notable Labs (Ticker: NTBL), holds 65.70K shares in Alexion Pharmaceuticals (Ticker: ALXN), holds ― shares in Intensity Therapeutics, Inc. (Ticker: INTS).
tipranks
Thomas Dubin

Thomas Dubin
Alexion Pharmaceuticals (ALXN)
SVP & CLO

Ranked #90,683 out of 98,123 Corporate Insiders

Profitable Transactions

18%
6 out of 34 Profitable Transactions

Average Return

-15.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$26K
100.00%
0.00%
A breakdown of Thomas Dubin's holdings

Insider Roles

Notable Labs
(NTBL)
Director
Intensity Therapeutics, Inc.
(INTS)
Director
Roles that Thomas Dubin holds in companies

Most Profitable Insider Trade

Stock:
Alexion Pharmaceuticals
(ALXN)
Rating:Informative Buy
Date:Aug 24, 2011 - Aug 24, 2012
Return:+25.00%
The most profitable trade made by Thomas Dubin

Thomas Dubin's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ALXN
Alexion Pharmaceuticals
Aug 27, 2012
Uninformative Sell
3.46M
$11.99M
Notable Labs
May 10, 2024
Director
Uninformative Buy
$25.60K
Intensity Therapeutics, Inc.
Director
List of latest transactions for each holding click on a transaction to see Thomas Dubin's performance on stock

Thomas Dubin insider profile FAQ

What is the percentage of profitable transactions made by Thomas Dubin?
The percentage of profitable transactions made by Thomas Dubin is 18%.
    What is the average return per transaction made by Thomas Dubin?
    The average return per transaction made by Thomas Dubin is -15.30%.
      What stocks does Thomas Dubin hold?
      Thomas Dubin holds: ALXN, NTBL, INTS stocks.
        What was Thomas Dubin’s latest transaction?
        Thomas Dubin latest transaction was an Uninformative Buy of ―.
          What was Thomas Dubin's most profitable transaction?
          Thomas Dubin’s most profitable transaction was an Informative Buy of ALXN stock on August 24, 2011. The return on the trade was 25.00%.
            What is Thomas Dubin's role in Alexion Pharmaceuticals?
            Thomas Dubin's role in Alexion Pharmaceuticals is SVP & CLO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.